Revista de Neurología y Neurociencia

  • ISSN: 2171-6625
  • Índice h de la revista: 17
  • Puntuación de cita de revista: 4.43
  • Factor de impacto de la revista: 3.38
Indexado en
  • Abrir puerta J
  • Genamics JournalSeek
  • El Factor de Impacto Global (GIF)
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • Directorio de indexación de revistas de investigación (DRJI)
  • OCLC-WorldCat
  • Convocatoria de búsqueda
  • Factor de impacto de revista científica (SJIF)
  • pub europeo
  • Google Académico
  • Laboratorios secretos de motores de búsqueda
Comparte esta página

Abstracto

Myasthenia Gravis: Challenges and Therapeutics Solution

Sandeep Kumar Singh, Vijay Kumar and Ashok Kumar

Myasthenia gravis (MG) is an autoimmune disease leading to fluctuating muscle weakness and fatigability and patients have autoantibodies against the acetylcholine receptor. MG is a postsynaptic dis¬order caused by the antibody-mediated destruction of acetyl-choline receptors (AChRs) and blockage of the binding of acetylcholine to acetylcholine receptor. Lambert-Eaton myasthenic syndrome (LEMS) is distinct autoimmune disorders that affect neuromuscular transmission. A study by Jee-Ae Kim et al. showing same clinical features and electrophysiological finding in patients of MG and LEMS